Difference between revisions of "Optimize Zn:fCu ratio"
Jump to navigation
Jump to search
(Created page with "The nineteenth intervention to reverse mild Alzheimer's in the Bredesen Protocol is: :'''Goal''': Optimize Zn:fCu ratio :'''Approach''': Depends on values obtained :'''...") |
m |
||
| Line 1: | Line 1: | ||
The nineteenth intervention to reverse mild Alzheimer's in the [[Bredesen Protocol]] is: | The nineteenth intervention to reverse mild Alzheimer's in the [[Bredesen Protocol]] is: | ||
:'''Goal''': Optimize Zn:fCu ratio | :'''Goal''': Optimize Zn:fCu ratio to 1:1 | ||
:'''Approach''': Depends on values obtained | :'''Approach''': Depends on values obtained | ||
| Line 16: | Line 16: | ||
Low serum zinc (<75mcg/dl) or RBC zinc, or high copper:zinc ratio (>1.3) | Low serum zinc (<75mcg/dl) or RBC zinc, or high copper:zinc ratio (>1.3) | ||
The next intervention is [[Ensure nocturnal oxygenation]]. | |||
The next intervention in the [[Bredesen Protocol]] is [[Ensure nocturnal oxygenation]]. | |||
Revision as of 00:16, 20 June 2016
The nineteenth intervention to reverse mild Alzheimer's in the Bredesen Protocol is:
- Goal: Optimize Zn:fCu ratio to 1:1
- Approach: Depends on values obtained
- References: Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease
Zinc is involved in multiple Alzheimer's-related metabolic processes, such as insulin resistance, chronic inflammation, ADAM10 proteolytic activity, and hormonal signaling.
One of the symptoms, signs, and laboratory values suggestive of type 3 Alzheimer's disease is Low serum zinc (<75mcg/dl) or RBC zinc, or high copper:zinc ratio (>1.3)
The next intervention in the Bredesen Protocol is Ensure nocturnal oxygenation.